{"transactions":[{"id":2862830,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2021-02-12T21:14:28.000Z","date":"2021-02-10","kind":"tax_withholding","acquired":false,"shares":5927,"price":25.95,"value":153805.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":215428,"source":{"system":"sec-edgar","filing":"0001192482-21-000147","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000147/edgar.xml","form_type":"4"}},{"id":2862829,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2021-02-12T21:14:28.000Z","date":"2021-02-10","kind":"tax_withholding","acquired":false,"shares":2564,"price":25.95,"value":66535.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of performance stock units."}],"balance_after":221355,"source":{"system":"sec-edgar","filing":"0001192482-21-000147","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000147/edgar.xml","form_type":"4"}},{"id":2899001,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2021-01-22T21:08:07.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":8161,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 19, 2021, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to 8,161 performance share units granted in two prior years."}],"balance_after":223919,"source":{"system":"sec-edgar","filing":"0001192482-21-000096","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000096/edgar.xml","form_type":"4/A","original_submission_date":"2021-01-21"}},{"id":2899000,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2021-01-22T21:08:07.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2022, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":215758,"source":{"system":"sec-edgar","filing":"0001192482-21-000096","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000096/edgar.xml","form_type":"4/A","original_submission_date":"2021-01-21"}},{"id":2900524,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Stock Option (Right to Purchase)","published_at":"2021-01-21T21:28:52.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2022, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":120000,"derivative":{"exercise_price":24.06,"expiration_date":"2031-01-19","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001192482-21-000084","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000084/edgar.xml","form_type":"4"}},{"id":2900523,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2021-01-21T21:28:52.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":8161,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 19, 2021, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to 8,161 performance share units granted in two prior years."}],"balance_after":223919,"source":{"system":"sec-edgar","filing":"0001192482-21-000084","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000084/edgar.xml","form_type":"4"}},{"id":2900522,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2021-01-21T21:28:52.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2022, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":215758,"source":{"system":"sec-edgar","filing":"0001192482-21-000084","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248221000084/edgar.xml","form_type":"4"}},{"id":3059981,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-08-12T20:06:24.000Z","date":"2020-08-10","kind":"tax_withholding","acquired":false,"shares":1515,"price":18.89,"value":28618.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":173758,"source":{"system":"sec-edgar","filing":"0001192482-20-000668","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000668/edgar.xml","form_type":"4"}},{"id":3276587,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-02-12T21:32:05.000Z","date":"2020-02-10","kind":"tax_withholding","acquired":false,"shares":4025,"price":21.62,"value":87020.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":175273,"source":{"system":"sec-edgar","filing":"0001192482-20-000153","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000153/edgar.xml","form_type":"4"}},{"id":3284309,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-02-07T21:09:32.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2021, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":31250,"derivative":{"exercise_price":21.34,"expiration_date":"2030-02-05","underlying":"Common Stock","underlying_shares":31250},"source":{"system":"sec-edgar","filing":"0001192482-20-000136","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000136/edgar.xml","form_type":"4"}},{"id":3284308,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-02-07T21:09:32.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":28125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2021, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":179298,"source":{"system":"sec-edgar","filing":"0001192482-20-000136","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000136/edgar.xml","form_type":"4"}},{"id":3305169,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2020-01-22T21:26:45.000Z","date":"2020-01-21","kind":"tax_withholding","acquired":false,"shares":214,"price":21.56,"value":4613.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":151173,"source":{"system":"sec-edgar","filing":"0001192482-20-000042","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248220000042/edgar.xml","form_type":"4"}},{"id":3439814,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2019-08-13T20:42:35.000Z","date":"2019-08-09","kind":"tax_withholding","acquired":false,"shares":1517,"price":11.24,"value":17051.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":151387,"source":{"system":"sec-edgar","filing":"0001192482-19-000335","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000335/edgar.xml","form_type":"4"}},{"id":3439813,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2019-08-13T20:42:35.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":797,"price":9.04,"value":7204.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired under the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan in a transaction exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":152904,"source":{"system":"sec-edgar","filing":"0001192482-19-000335","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000335/edgar.xml","form_type":"4"}},{"id":3457341,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2019-07-23T20:02:01.000Z","date":"2019-07-19","kind":"tax_withholding","acquired":false,"shares":181,"price":10.35,"value":1873.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":152107,"source":{"system":"sec-edgar","filing":"0001192482-19-000318","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000318/edgar.xml","form_type":"4"}},{"id":3665668,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2019-02-11T21:59:50.000Z","date":"2019-02-08","kind":"tax_withholding","acquired":false,"shares":2693,"price":14.39,"value":38752.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":152288,"source":{"system":"sec-edgar","filing":"0001192482-19-000071","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000071/edgar.xml","form_type":"4"}},{"id":3683686,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Stock Option (Right to Purchase)","published_at":"2019-01-29T21:39:56.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2020, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":32000,"derivative":{"exercise_price":15.9,"expiration_date":"2029-01-25","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001192482-19-000057","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000057/edgar.xml","form_type":"4"}},{"id":3683685,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2019-01-29T21:39:56.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2020, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock."}],"balance_after":154981,"source":{"system":"sec-edgar","filing":"0001192482-19-000057","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000057/edgar.xml","form_type":"4"}},{"id":3689221,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2019-01-23T21:13:12.000Z","date":"2019-01-18","kind":"tax_withholding","acquired":false,"shares":214,"price":15.76,"value":3372.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":122981,"source":{"system":"sec-edgar","filing":"0001192482-19-000037","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248219000037/edgar.xml","form_type":"4"}},{"id":3832610,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-08-27T20:07:45.000Z","date":"2018-08-23","kind":"tax_withholding","acquired":false,"shares":599,"price":18.03,"value":10799.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":123195,"source":{"system":"sec-edgar","filing":"0001192482-18-000415","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248218000415/edgar.xml","form_type":"4"}},{"id":3851781,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-08-06T21:43:50.000Z","date":"2018-08-03","kind":"tax_withholding","acquired":false,"shares":181,"price":20.15,"value":3647.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":123794,"source":{"system":"sec-edgar","filing":"0001192482-18-000380","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248218000380/edgar.xml","form_type":"4"}},{"id":3851780,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-08-06T21:43:50.000Z","date":"2018-07-27","kind":"grant","acquired":true,"shares":539,"price":15.84,"value":8537.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":123975,"source":{"system":"sec-edgar","filing":"0001192482-18-000380","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248218000380/edgar.xml","form_type":"4"}},{"id":3884844,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-06-22T22:25:20.000Z","date":"2018-06-21","kind":"sale","acquired":false,"shares":4900,"price":28.35,"value":138915.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.84 to $28.55, inclusive."}],"balance_after":123436,"source":{"system":"sec-edgar","filing":"0001192482-18-000320","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248218000320/edgar.xml","form_type":"4"}},{"id":3884843,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-06-22T22:25:20.000Z","date":"2018-06-21","kind":"sale","acquired":false,"shares":5100,"price":27.5,"value":140250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.80 to $27.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":128336,"source":{"system":"sec-edgar","filing":"0001192482-18-000320","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248218000320/edgar.xml","form_type":"4"}},{"id":4023486,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-03-01T21:03:54.000Z","date":"2018-02-26","kind":"tax_withholding","acquired":false,"shares":1197,"price":21.77,"value":26058.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":133436,"source":{"system":"sec-edgar","filing":"0001192482-18-000098","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248218000098/edgar.xml","form_type":"4"}},{"id":4073544,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-02-06T21:18:36.000Z","date":"2018-02-05","kind":"tax_withholding","acquired":false,"shares":214,"price":23.38,"value":5003.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":134633,"source":{"system":"sec-edgar","filing":"0001192482-18-000078","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248218000078/edgar.xml","form_type":"4"}},{"id":4086336,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Stock Option (Right to Purchase)","published_at":"2018-01-30T00:38:10.000Z","date":"2018-01-25","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable over a four-year period commencing on February 10, 2018.  Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2019, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer."}],"balance_after":50000,"derivative":{"exercise_price":24.35,"expiration_date":"2028-01-25","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001192482-18-000063","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248218000063/edgar.xml","form_type":"4"}},{"id":4086335,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-01-30T00:38:10.000Z","date":"2018-01-26","kind":"grant","acquired":true,"shares":1044,"price":10.17,"value":10617.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares were acquired under the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":134847,"source":{"system":"sec-edgar","filing":"0001192482-18-000063","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248218000063/edgar.xml","form_type":"4"}},{"id":4086334,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-01-30T00:38:10.000Z","date":"2018-01-25","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest over a four-year period commencing on February 10, 2018.  Twenty-five percent (25%) of the restricted stock units vest on February 10, 2019, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vest date in shares of the issuer's common stock."}],"balance_after":133803,"source":{"system":"sec-edgar","filing":"0001192482-18-000063","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248218000063/edgar.xml","form_type":"4"}},{"id":4086333,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2018-01-30T00:38:10.000Z","date":"2017-12-14","kind":"gift","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":108803,"source":{"system":"sec-edgar","filing":"0001192482-18-000063","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248218000063/edgar.xml","form_type":"4"}},{"id":4242190,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2017-08-04T20:15:45.000Z","date":"2017-08-04","kind":"tax_withholding","acquired":false,"shares":200,"price":12.39,"value":2478.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":110803,"source":{"system":"sec-edgar","filing":"0001192482-17-000214","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248217000214/edgar.xml","form_type":"4"}},{"id":4242189,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2017-08-04T20:15:45.000Z","date":"2017-07-28","kind":"grant","acquired":true,"shares":776,"price":10.6,"value":8225.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired under the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan in a transaction exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":111003,"source":{"system":"sec-edgar","filing":"0001192482-17-000214","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248217000214/edgar.xml","form_type":"4"}},{"id":4320608,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2017-05-15T21:26:12.000Z","date":"2017-05-12","kind":"purchase","acquired":true,"shares":10000,"price":9.18,"value":91800.0,"ownership":{"direct":true},"balance_after":110227,"source":{"system":"sec-edgar","filing":"0001192482-17-000127","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248217000127/edgar.xml","form_type":"4"}},{"id":4376306,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2017-03-21T20:44:49.000Z","date":"2017-03-17","kind":"tax_withholding","acquired":false,"shares":388,"price":14.95,"value":5800.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":100227,"source":{"system":"sec-edgar","filing":"0001192482-17-000087","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248217000087/edgar.xml","form_type":"4"}},{"id":4448477,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Stock Option (Right to Purchase)","published_at":"2017-02-14T22:53:32.000Z","date":"2017-02-10","kind":"grant","acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable over a four-year period commencing on February 10, 2017.  Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2018, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the employee's continued service with the issuer."}],"balance_after":32500,"derivative":{"exercise_price":15.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001192482-17-000039","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248217000039/edgar.xml","form_type":"4"}},{"id":4448476,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2017-02-14T22:53:32.000Z","date":"2017-02-10","kind":"grant","acquired":true,"shares":16250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest over a four-year period commencing on February 10, 2017.  Twenty-five percent (25%) of the restricted stock units vest on February 10, 2018, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the remaining three years of the four-year period, subject to the employee's continued service with the issuer. The restricted stock units will be settled on each applicable vest date in shares of the issuer's common stock."}],"balance_after":100615,"source":{"system":"sec-edgar","filing":"0001192482-17-000039","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248217000039/edgar.xml","form_type":"4"}},{"id":4448475,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":142703,"kind":"person","name":"Brannelly Paul","position":1,"cik":"0001394936","reported_name":"Brannelly Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President & CFO"}}],"security":"Common Stock","published_at":"2017-02-14T22:53:32.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":1006,"price":10.08,"value":10140.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired under the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":84365,"source":{"system":"sec-edgar","filing":"0001192482-17-000039","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000119248217000039/edgar.xml","form_type":"4"}}]}